We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




Mechanism that Controls Production of Egg-Laying Hormone

By Biotechdaily staff writers
Posted on 05 Mar 2003
A recent study has found that protein production during egg laying in the sea slug Aplysia is mediated by a mechanism similar to that used by viruses when they take control of a cell's ribosomes. More...
The study appeared in the February 18, 2003, online edition of Nature Neuroscience.

Viruses seize control of the cell's protein synthetic apparatus (the ribosomes) by using an internal ribosome entry site (IRES), which shuts down and bypasses the normal mechanisms that regulate binding of messenger RNAs to ribosomes. The cells stop making their normal proteins and switch to production of viral proteins. These IRES sites are normal features of viral RNA but are very rare in the RNA of normal cells.

In the current study, investigators from McGill University (Montreal, Canada) observed that during egg laying, Aplysia produced massive amounts of egg-laying hormone (ELH). Furthermore, the ELH messenger RNA was found to contain an IRES. After egg laying takes place, nerve cells producing ELH switched from the normal cellular mechanism of protein production to one that used the IRES. This switch allowed for massive amounts of ELH protein to be produced at the expense of other cellular proteins, mimicking the behavior of viruses during infection of a host cell.

"Egg laying is an important investment for an animal, thus when stimulated to do so, it wants to get it right,” explained senior author Dr. Wayne Sossin, an investigator at McGill University's Montreal Neurological Institute. "In order to do this, the cell must make a lot of ELH protein in a short period of time to signal the release of eggs. One way to do this is to temporarily stop making other proteins and concentrate on making one particular protein – in this instance, the ELH.”



Related Links:
McGill University

Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
Complement 3 (C3) Test
GPP-100 C3 Kit
Gold Member
COVID-19 Antigen Self-Test
Panbio COVID-19 Antigen Self-Test
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.